Transscleral contact retinal photocoagulation with an 810-nm semiconductor diode laser

T. Jennings, T. Fuller, J. A. Vukich, T. T. Lam, B. C. Joondeph, B. Ticho, N. P. Blair, D. P. Edward

Research output: Contribution to journalArticle

Abstract

Since the 810-nm wavelength has marked transmissibility through the sclera and absorption by melanin, it would be ideal for transscleral photocoagulation. We performed experiments to determine if consistent transscleral chorioretinal lesions could be produced in Dutch belted pigmented rabbits using the 810-nm laser, and if this modality caused less blood-retinal barrier disruption than retinal cryopexy of clinically equivalent treatment areas. The laser applications produced whitish to grayish-white retinal lesions when the surgeon, under direct visualization, used low powers and long durations (5 to 10 seconds), and controlled the treatment duration. Histopathologic evaluation of a lesion demonstrated an intact sclera overlying the chorioretinal lesion. Vitreous protein concentration, which was measured to assess blood-retinal barrier disruption, was significantly less in eyes treated with transscleral photocoagulation than in eyes treated with cryopexy of clinically equivalent treatment areas. We conclude that transscleral 810-nm laser treatment may be a viable clinical alternative to retinal cryopexy.

Original languageEnglish (US)
Pages (from-to)492-496
Number of pages5
JournalOphthalmic Surgery
Volume21
Issue number7
StatePublished - 1990
Externally publishedYes

Fingerprint

Semiconductor Lasers
Light Coagulation
Blood-Retinal Barrier
Sclera
Lasers
Melanins
Therapeutics
Rabbits
Proteins

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Jennings, T., Fuller, T., Vukich, J. A., Lam, T. T., Joondeph, B. C., Ticho, B., ... Edward, D. P. (1990). Transscleral contact retinal photocoagulation with an 810-nm semiconductor diode laser. Ophthalmic Surgery, 21(7), 492-496.

Transscleral contact retinal photocoagulation with an 810-nm semiconductor diode laser. / Jennings, T.; Fuller, T.; Vukich, J. A.; Lam, T. T.; Joondeph, B. C.; Ticho, B.; Blair, N. P.; Edward, D. P.

In: Ophthalmic Surgery, Vol. 21, No. 7, 1990, p. 492-496.

Research output: Contribution to journalArticle

Jennings, T, Fuller, T, Vukich, JA, Lam, TT, Joondeph, BC, Ticho, B, Blair, NP & Edward, DP 1990, 'Transscleral contact retinal photocoagulation with an 810-nm semiconductor diode laser', Ophthalmic Surgery, vol. 21, no. 7, pp. 492-496.
Jennings T, Fuller T, Vukich JA, Lam TT, Joondeph BC, Ticho B et al. Transscleral contact retinal photocoagulation with an 810-nm semiconductor diode laser. Ophthalmic Surgery. 1990;21(7):492-496.
Jennings, T. ; Fuller, T. ; Vukich, J. A. ; Lam, T. T. ; Joondeph, B. C. ; Ticho, B. ; Blair, N. P. ; Edward, D. P. / Transscleral contact retinal photocoagulation with an 810-nm semiconductor diode laser. In: Ophthalmic Surgery. 1990 ; Vol. 21, No. 7. pp. 492-496.
@article{a3223ac11cc648ff88e8b8e8c1e954b5,
title = "Transscleral contact retinal photocoagulation with an 810-nm semiconductor diode laser",
abstract = "Since the 810-nm wavelength has marked transmissibility through the sclera and absorption by melanin, it would be ideal for transscleral photocoagulation. We performed experiments to determine if consistent transscleral chorioretinal lesions could be produced in Dutch belted pigmented rabbits using the 810-nm laser, and if this modality caused less blood-retinal barrier disruption than retinal cryopexy of clinically equivalent treatment areas. The laser applications produced whitish to grayish-white retinal lesions when the surgeon, under direct visualization, used low powers and long durations (5 to 10 seconds), and controlled the treatment duration. Histopathologic evaluation of a lesion demonstrated an intact sclera overlying the chorioretinal lesion. Vitreous protein concentration, which was measured to assess blood-retinal barrier disruption, was significantly less in eyes treated with transscleral photocoagulation than in eyes treated with cryopexy of clinically equivalent treatment areas. We conclude that transscleral 810-nm laser treatment may be a viable clinical alternative to retinal cryopexy.",
author = "T. Jennings and T. Fuller and Vukich, {J. A.} and Lam, {T. T.} and Joondeph, {B. C.} and B. Ticho and Blair, {N. P.} and Edward, {D. P.}",
year = "1990",
language = "English (US)",
volume = "21",
pages = "492--496",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",
number = "7",

}

TY - JOUR

T1 - Transscleral contact retinal photocoagulation with an 810-nm semiconductor diode laser

AU - Jennings, T.

AU - Fuller, T.

AU - Vukich, J. A.

AU - Lam, T. T.

AU - Joondeph, B. C.

AU - Ticho, B.

AU - Blair, N. P.

AU - Edward, D. P.

PY - 1990

Y1 - 1990

N2 - Since the 810-nm wavelength has marked transmissibility through the sclera and absorption by melanin, it would be ideal for transscleral photocoagulation. We performed experiments to determine if consistent transscleral chorioretinal lesions could be produced in Dutch belted pigmented rabbits using the 810-nm laser, and if this modality caused less blood-retinal barrier disruption than retinal cryopexy of clinically equivalent treatment areas. The laser applications produced whitish to grayish-white retinal lesions when the surgeon, under direct visualization, used low powers and long durations (5 to 10 seconds), and controlled the treatment duration. Histopathologic evaluation of a lesion demonstrated an intact sclera overlying the chorioretinal lesion. Vitreous protein concentration, which was measured to assess blood-retinal barrier disruption, was significantly less in eyes treated with transscleral photocoagulation than in eyes treated with cryopexy of clinically equivalent treatment areas. We conclude that transscleral 810-nm laser treatment may be a viable clinical alternative to retinal cryopexy.

AB - Since the 810-nm wavelength has marked transmissibility through the sclera and absorption by melanin, it would be ideal for transscleral photocoagulation. We performed experiments to determine if consistent transscleral chorioretinal lesions could be produced in Dutch belted pigmented rabbits using the 810-nm laser, and if this modality caused less blood-retinal barrier disruption than retinal cryopexy of clinically equivalent treatment areas. The laser applications produced whitish to grayish-white retinal lesions when the surgeon, under direct visualization, used low powers and long durations (5 to 10 seconds), and controlled the treatment duration. Histopathologic evaluation of a lesion demonstrated an intact sclera overlying the chorioretinal lesion. Vitreous protein concentration, which was measured to assess blood-retinal barrier disruption, was significantly less in eyes treated with transscleral photocoagulation than in eyes treated with cryopexy of clinically equivalent treatment areas. We conclude that transscleral 810-nm laser treatment may be a viable clinical alternative to retinal cryopexy.

UR - http://www.scopus.com/inward/record.url?scp=0025040218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025040218&partnerID=8YFLogxK

M3 - Article

C2 - 2398999

AN - SCOPUS:0025040218

VL - 21

SP - 492

EP - 496

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 7

ER -